Inactive Instrument

Analyst Reco. AIB Group plc Deutsche Boerse AG

Equities

Berenberg cuts Keywords Studios to 'hold'	07-03	AN
AstraZeneca target raised; Antofagasta lowered	05-07	AN
AIB GROUP : Stronger revenue growth and a benign cost of risk	05-03
AIB GROUP : EPS cuts on stronger net interest margin normalisation	03-14
AIB GROUP : Upgraded mid-term profitability objectives	03-06
UBS raises GSK and cuts AstraZeneca	01-16	AN
Goldman Sachs Downgrades AIB Group to Neutral from Buy, Cuts PT	12-01	MT
AIB GROUP : EPS upgrades on higher net interest income	11-14
AIB GROUP : Ongoing revenue guidance upgrade	11-02
POLISH GENERAL ELECTIONS : Civic Platform victory brings sunnier skies for banks	23-10-16
EUROPEAN BANK TAXATION : where will the lightning strike next?	23-10-10
Berenberg Boosts AIB Group PT, Maintains Buy Rating	23-10-09	MT
CLIMATE STRESS TESTS : the worst-case scenario is the best	23-09-07
AIB GROUP : EPS upgrades on increased net interest income projections	23-08-25
AIB GROUP : Indecent profitability levels	23-08-03
AIB GROUP : EPS upgrade on updated NIM guidance	23-05-09
AIB GROUP : Net interest margin upgrade	23-05-04
EC to propose an SVB-like resolution approach	23-04-13
Is SVB the canary into the coal mine?	23-03-10
AIB GROUP : EPS upgrades on skyrocketing margins	23-03-09

No results for this search

AIB GROUP : Stronger revenue growth and a benign cost of risk

May 03, 2024 at 06:22 am